Results 31 to 40 of about 3,328,268 (306)

Evaluation of fibrinolytic and antioxidant effects of Allium affine hydroalcoholic extract

open access: yesResearch in Pharmaceutical Sciences, 2017
Allium affine is a member of Amaryllidaceae family, which grows wildly in some western regions of Iran. Limited information is available about the pharmacological activities of this plant.
Masoud Sadeghi   +3 more
doaj   +1 more source

Spectrophotometric analysis of thrombolytic activity: SATA assay [PDF]

open access: yes, 2017
Introduction: Measurement of thrombolytic activity i.e. clot lysis is crucial for research and development of novel thrombolytics. It is also a key factor in assessment of the effectiveness of conventionally used thrombolytic agents in the clinic, which ...
Entekhabi, Nazila   +5 more
core   +2 more sources

Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study [PDF]

open access: yes, 2007
Objective: Postoperative bleeding is still one of the most common complications of cardiac surgery. Antifibrinolytic agents successfully reduce bleeding, but there are controversies concerning adverse effects after their systemic use.
Barić, Davor   +7 more
core   +1 more source

Non-sterile Submerged Fermentation of Fibrinolytic Enzyme by Marine Bacillus subtilis Harboring Antibacterial Activity With Starvation Strategy

open access: yesFrontiers in Microbiology, 2019
Microbial fibrinolytic enzyme is a promising candidate for thrombolytic therapy. Non-sterile production of fibrinolytic enzyme by marine Bacillus subtilis D21-8 under submerged fermentation was realized at a mild temperature of 34°C, using a unique ...
Shihan Pan   +4 more
doaj   +1 more source

Fibrinolytic Enzyme from Green Microalgae: A New Potential Drug for Thrombolytic Therapy?

open access: yesPhycology, 2023
Thrombosis is characterized by the pathological formation of fibrin clots within a blood vessel, leading to the obstruction of blood flow. Fibrinolytic enzymes from microorganisms have been shown to be more efficient and safer in dissolving clots.
Yanara Alessandra Santana Moura   +5 more
doaj   +1 more source

Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury

open access: yesPLoS ONE, 2013
Background Critically ill patients frequently develop acute lung injury (ALI). Disturbed alveolar fibrin turnover, a characteristic feature of ALI, is the result of both activation of coagulation and inhibition of fibrinolysis.
J. Hofstra   +9 more
semanticscholar   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

open access: yesHayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani   +5 more
doaj   +1 more source

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

open access: yesAnnals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan   +11 more
doaj   +1 more source

Biophysical Mechanisms Mediating Fibrin Fiber Lysis [PDF]

open access: yes, 2017
The formation and dissolution of blood clots is both a biochemical and a biomechanical process. While much of the chemistry has been worked out for both processes, the influence of biophysical properties is less well understood. This review considers the
Hudson, Nathan E.
core   +9 more sources

Food Origin Fibrinolytic Enzyme With Multiple Actions

open access: yesHayati Journal of Biosciences, 2017
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy